Last updated: April 24, 2026
Who Supplies Dextrose 10% and Sodium Chloride 0.9% in Plastic Containers?
Dextrose 10% and sodium chloride 0.9% in plastic containers are supplied by major sterile-injectable manufacturers and contract packaging partners globally. Supply channels typically split into (1) pharmaceutical-manufacturing sites producing the sterile solutions and (2) packaging and private-label pathways that place product into plastic containers (commonly flexible bags, and in some markets semi-rigid plastic systems), then distribute to hospitals, wholesalers, and government tenders.
What product formats and container types define the supply chain?
Supply references for “Dextrose 10% and Sodium Chloride 0.9% in plastic container” usually map to one of these sterile supply formats:
- Flexible plastic infusion bags (IV): the most common “plastic container” form for this combination in many markets.
- Pre-filled plastic containers (less common for this specific combination depending on country): used where the tender specifies a specific container system.
In procurement documents, the container is typically characterized as:
- “plastic container” (generic)
- “flexible container” (common in IV fluid catalogs)
- “single-dose container” and a stated fill volume (e.g., 250 mL, 500 mL, 1,000 mL)
Which manufacturers supply the finished sterile IV solution in plastic containers?
The most reliable supplier set for this drug class is built from the companies that publish sterile IV product catalogs and/or sell packaged, regulated sterile solutions through distributors and tender channels.
Global finished-product manufacturers (sterile IV fluids)
The following manufacturers are established providers of IV infusion solutions (including dextrose and sodium chloride combinations) in plastic containers across multiple geographies:
| Supplier |
Corporate scope in IV fluids |
Typical distribution pattern |
| Fresenius Kabi |
IV solutions including dextrose and sodium chloride products in hospital supply channels |
Direct tenders and wholesale distribution |
| B. Braun |
Sterile IV fluids portfolio with plastic-container presentation in multiple markets |
Hospital and government tenders |
| Baxter |
Large sterile fluids manufacturing footprint; supplies into hospital channels |
Distributor + tender supply |
| Otsuka / Otsuka Pharmaceutical (market-dependent) |
In some countries supplies IV dextrose/saline formulations under local licensing |
Local distributor + tenders |
| Hospira / Pfizer legacy supply (market-dependent) |
Historical IV sterile portfolio; active supply depends on country |
Distributor networks where still marketed |
Note: Brand names and exact package configurations vary by country (same active ingredients, different labeling, strengths, and bag sizes).
Who supplies through contract manufacturing and private-label pathways?
In many tenders, the “supplier” is the tender winning manufacturer in the regulatory market. Under the hood, contract manufacturing and packaging can contribute, especially where the label is assigned to a local marketing authorization holder.
Common contracting pathways:
- Sterile manufacturing subcontracting for solution preparation and aseptic fill
- Packaging sub-contracting where the plastic bag system and labeling are applied to meet local market rules
- Repack or re-labeling for national tender compliance
This is typical for:
- Countries with tight procurement cycles where multiple sources must qualify
- Markets where the marketing authorization holder uses multiple manufacturing sites
Which contract packagers and packaging system suppliers touch this product?
Plastic infusion container systems used for sterile IV fluids are supplied by specialized packaging manufacturers and film/bag system providers. These suppliers do not always sell the finished “drug” directly, but they supply the container systems that make the “plastic container” requirement achievable at scale.
Key packaging-system supplier categories include:
- Flexible infusion bag system providers (film, heat-sealed bag systems, compatible ports)
- Stopper/connector components suppliers (where valve and connector standards drive compatibility)
- Form-fill-finish specialists (in contract sterile packaging lines)
How to map suppliers to tenders in practice
Procurement teams usually identify suppliers through:
- Marketing authorization holder listed on the tender document or local drug register
- NDC/GTIN or local SKU that ties to a specific package size and container system
- Manufacturer of record (often listed on the labeling or tender technical sheet)
- Case pack and unit count tied to the plastic bag system
Your most actionable route for identifying true “suppliers” is to list companies that appear as:
- Marketing authorization holders for the exact combination
- Tender-product manufacturers for the exact container type and fill volume
- Wholesaler/distributor named in the procurement schedule
Country-specific supplier sets (what procurement usually reveals)
Because the product is regulated locally, the supplier list changes by country based on market authorizations, tender status, and line clearance. The typical pattern looks like this:
- Large multi-national sterile IV vendors win a share of tenders because they already qualify for hospital procurement and regulatory listings.
- Local marketing authorizations often select one of the multinational manufacturers for supply, then list a local distributor as “supplier.”
- Price-driven tenders can shift supplier mix quickly when alternative products meet the same specification (same active ingredients, same concentration, same container and volume).
Specification checks that determine whether a company qualifies
Even when multiple suppliers sell IV saline/dextrose products, qualification can hinge on:
- Concentrations: “Dextrose 10%” and “Sodium chloride 0.9%”
- Sterility and intended use: intravenous infusion
- Container: plastic container (frequently flexible bag)
- Volume and presentation: e.g., 250 mL, 500 mL, 1,000 mL (varies by market)
- Administration compatibility: connector/port system and labeling requirements
Actionable supplier shortlist structure for sourcing
For procurement and R&D vendor qualification, structure the shortlist into two layers:
Layer 1: finished-product manufacturers
Aim to qualify suppliers from firms with broad sterile IV manufacturing footprints:
- Fresenius Kabi
- B. Braun
- Baxter
Layer 2: market-authorized sellers or distributors
Use tender documents to identify the actual sell-through channel:
- local wholesalers and hospital procurement group channels
- marketing authorization holders in the country of use
Key Takeaways
- Suppliers for “Dextrose 10% and Sodium Chloride 0.9% in plastic container” are typically the same large multinational sterile IV manufacturers that supply dextrose and saline IV fluids at scale.
- In tender reality, the “supplier” label usually reflects the market authorization holder and local distributor, even when the manufacturing site sits with a multinational sterile IV vendor.
- Qualification is determined by exact concentration, container system, and volume, not only the active ingredients.
FAQs
1) Are these supplied as flexible bags in plastic?
In many markets, yes. Procurement documents commonly describe these IV fluids as supplied in “plastic containers,” with flexible infusion bags being the dominant format for sterile IV solutions.
2) Do the same suppliers also provide single-agent dextrose or saline products?
Yes. Major sterile IV vendors typically supply broad portfolios that include dextrose and sodium chloride products, and the combination product is an extension of that manufacturing capability.
3) Who is the “supplier” in tenders: manufacturer or distributor?
Usually the tender listing names the marketing authorization holder and/or distributor who sells to the procurement entity, even if the underlying manufacture is by a third-party site.
4) What determines whether a supplier qualifies for the “plastic container” requirement?
The tender’s container specification ties to the plastic bag system and the connector/port standard, plus packaging configuration and fill volume.
5) Can supplier lists change quarter-to-quarter?
Yes. Hospital and government tenders frequently switch suppliers based on pricing, product availability, and regulatory tender eligibility while keeping the same active concentrations.
References
[1] Fresenius Kabi. Product portfolio and IV solutions information (company website).
[2] B. Braun. IV solutions and sterile pharmaceuticals portfolio (company website).
[3] Baxter. Sterile IV fluids and infusion therapies portfolio (company website).
[4] European Medicines Agency (EMA). Public assessment and product information for IV medicinal products (database).
[5] U.S. FDA. Drug product labeling and listing resources for IV solutions (public databases).
